Virus News and Research

Latest Virus News and Research

SARS-CoV-2 viroporin triggers NLRP3 inflammasome causing a severe inflammatory response

Now, a team of researchers at the University of Florida report that the SARS-CoV-2 viroporin triggers the NLR Family Pyrin Domain Containing 3 (NLRP3) inflammasome, which is responsible for the inflammatory pathology in severely ill COVID-19 patients.

30 Oct 2020

Symptoms and outcomes of 3.32 million people tested for SARS-CoV-2

A recent study published on the preprint server medRxiv* in October 2020 shows the need for large-scale studies on the clinical characteristics and outcomes of COVID-19 at the national and international scale. This is essential to shape interventions and optimize the use of resources to contain and manage a second wave of the pandemic.

30 Oct 2020

A2B-COVID: Rapid identification of SARS-CoV-2 transmission

A new study published on the preprint server medRxiv in October 2020 reports a method to assess transmission potential for any event in the current pandemic, using what is known about the virus's spread, data on the mobility of individuals, and new ways of processing genomic sequencing data. The outcome is to determine whether cases are linked or not so as to take action to prevent further spread.

29 Oct 2020

MD65 IgG-YTE shows powerful post-exposure neutralization of SARS-CoV-2

A recent study published in the preprint server bioRxiv in October 2020 describes a reliable animal model to demonstrate the powerful capacity of human neutralizing mAbs directed against SARS-CoV-2 to prevent viral binding the host cell receptor and thus block infection. This indicates the lifesaving value of mAbs in severe COVID-19.

29 Oct 2020

UH and CWRU announce Phase 3 trial of Astrazeneca's investigational COVID-19 vaccine

University Hospitals and Case Western Reserve University announced today that UH Cleveland Medical Center has been selected as a clinical trial site for the Phase 3 global study of an investigational vaccine against SARS-CoV-2, sponsored by AstraZeneca.

29 Oct 2020

Researchers identify a novel SARS-CoV-2 variant that spread widely across Europe in summer 2020

Researchers from Basel and Spain have identified a novel SARS-CoV-2 variant that has spread widely across Europe in recent months, according to an un-peer-reviewed preprint released this week.

29 Oct 2020

Toxin-carrying virus implicated in the emergence of new Salmonella strain in pigs

Researchers at the Quadram Institute have implicated a toxin-carrying virus in the emergence of a new strain of Salmonella in pigs.

29 Oct 2020

DETECT study: Wearable fitness devices can improve public health efforts to control COVID-19

Examining data from the first six weeks of their landmark DETECT study, a team of scientists from the Scripps Research Translational Institute sees encouraging signs that wearable fitness devices can improve public health efforts to control COVID-19.

29 Oct 2020

Study examines COVID-19-related tweets to uncover public opinions, sentiments and trends

Twitter users initially didn't feel positive about the state of the economy, prevention, treatment and recovery concerning COVID-19.

29 Oct 2020

Dietary restriction effective in reducing the odds of developing liver cancer from fatty liver

Liver cancer from too much fat accumulation in the liver has been increasing in many countries including Japan.

29 Oct 2020

Antiviral inhibitor DDX42 shows broad activity against Chikungunya, HIV and SARS-CoV-2

By exploiting type 1 interferon's ability to foster an antagonistic cellular environment for viral replication, a research group from France pinpointed DEAD-box RNA helicase DDX42 as an intrinsic inhibitor of HIV, but also other pathogenic viruses such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Chikungunya virus.

29 Oct 2020

Researchers test effectiveness of different fabric masks at filtering particles

A team of researchers have tested everything from t-shirts and socks to jeans and vacuum bags to determine what type of mask material is most effective at trapping the ultrafine particles which may contain viruses such as SARS-CoV-2, the virus which causes COVID-19.

29 Oct 2020

New method could help increase effectiveness of vaccines against coronavirus

A University at Buffalo-led research team has discovered a technique that could help increase the effectiveness of vaccines against the novel coronavirus, the virus that causes COVID-19.

29 Oct 2020

Research shows why certain people infected with COVID-19 show no symptoms

Researchers worldwide have been surprised to see that individuals can be infected with the SARS-CoV-2 virus - the virus that produces COVID-19 - without showing symptoms. Since these individuals expose others to infection without knowing it, it is important to find an explanation and hopefully a solution to this.

29 Oct 2020

Majority of people infected with mild-to-moderate COVID 19 mount robust antibody response

The vast majority of individuals infected with mild-to-moderate COVID 19 mount a robust antibody response that is relatively stable for at least five months, according to research conducted at the Icahn School of Medicine at Mount Sinai and published October 28, in the journal Science.

29 Oct 2020

Researchers estimate prevalence of SARS-CoV-2 antibodies among adults in orange county

Testing a representative sample of Orange County residents for a wide range of coronavirus antibodies, University of California, Irvine researchers found that 11.5 percent of them have antibodies for COVID-19, in contrast to previous estimates of less than 2 percent.

29 Oct 2020

New report offers guidance on cardiac screening of athletes infected with COVID-19

Reports have indicated that COVID-19 may cause heart damage in hospitalized patients with severe cases of the disease, but it's unclear whether cardiac injury also occurs in infected patients who are asymptomatic or experience only mild symptoms.

29 Oct 2020

Mouth may be primary route of SARS-CoV-2 infection and transmission

A new study published on the preprint server medRxiv in October 2020 shows that the virus also multiplies robustly in the oral cavity, indicating that saliva plays a role in viral transmission.

29 Oct 2020

Travel surges before lockdown undermine the SARS-CoV-2 containment effort

Recently, researchers from the Harvard T.H. Chan School of Public Health, Boston; the University of Illinois at Urbana Champaign; and the University of California, USA, assessed the impact of the announcement and implementation of restrictions such as lockdowns on mobility patterns of humans.

28 Oct 2020

COVID-19 mortality rate declines significantly in Sweden

A new observational study by Swedish researchers shows a significant decline in death rates among hospitalized patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Their study titled, "Decline in mortality among hospitalized covid-19 patients in Sweden: a nationwide observational study," was released online as a preprint on the medRxiv* server.

28 Oct 2020

Virus News and Research

Latest Virus News and Research

SARS-CoV-2 viroporin triggers NLRP3 inflammasome causing a severe inflammatory response

Symptoms and outcomes of 3.32 million people tested for SARS-CoV-2

A2B-COVID: Rapid identification of SARS-CoV-2 transmission

MD65 IgG-YTE shows powerful post-exposure neutralization of SARS-CoV-2

UH and CWRU announce Phase 3 trial of Astrazeneca's investigational COVID-19 vaccine

Researchers identify a novel SARS-CoV-2 variant that spread widely across Europe in summer 2020

Toxin-carrying virus implicated in the emergence of new Salmonella strain in pigs

DETECT study: Wearable fitness devices can improve public health efforts to control COVID-19

Study examines COVID-19-related tweets to uncover public opinions, sentiments and trends

Dietary restriction effective in reducing the odds of developing liver cancer from fatty liver

Antiviral inhibitor DDX42 shows broad activity against Chikungunya, HIV and SARS-CoV-2

Researchers test effectiveness of different fabric masks at filtering particles

New method could help increase effectiveness of vaccines against coronavirus

Research shows why certain people infected with COVID-19 show no symptoms

Majority of people infected with mild-to-moderate COVID 19 mount robust antibody response

Researchers estimate prevalence of SARS-CoV-2 antibodies among adults in orange county

New report offers guidance on cardiac screening of athletes infected with COVID-19

Mouth may be primary route of SARS-CoV-2 infection and transmission

Travel surges before lockdown undermine the SARS-CoV-2 containment effort

COVID-19 mortality rate declines significantly in Sweden

A new way of characterising biomolecules eBook

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Newsletters you may be interested in